Stock Rating Upgrade
The Value Trend Rating for Dr Reddy’S Laboratories Ltd (NYSE: RDY) rose significantly recently from D to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Dr Reddy’S Laboratories Ltd (NYSE: RDY) stock closed at $15.11 on 11/8/24 after a slight gain of 0.1%. However, trading volume in this advance was unusually low at 62% of normal. Relative to the market the stock has been strong over the last nine months but has declined -79.6% during the last week.
Current PriceTarget Research Rating
RDY is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Dr Reddy’S Laboratories has a current Value Trend Rating of B (Positive). This VT Rating rose significantly in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Dr Reddy’S Laboratories has a slightly positive Power Rating of 62 and a good Appreciation Score of 73, producing the Positive Value Trend Rating.
Be the first to comment